Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00170976
Status:
COMPLETED
Last Update Posted:
2023-10-12
First Post:
2005-09-10
Brief Title:
A Year Long Study to Evaluate the Safety of the Combination of Valsartan 320 mg and Amlodipine 5 mg in Patients With Hypertension
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
A 54 Week Extension to the Double-blind Multicenter Multifactorial Placebo-controlled Study to Evaluate the Efficacy and Safety of Valsartan 160 mg and 320 mg and Amlodipine 10 mg Combined and Alone in Hypertensive Patients
Status:
COMPLETED
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A ONE YEAR SAFETY STUDY FOR PATIENTS WHO COMPLETE STUDY VAA489A2307
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None